Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Vivani Medical, Inc. before investing.

In this article, we go over a few key elements for understanding Vivani Medical, Inc.’s stock price such as:

• Vivani Medical, Inc.’s current stock price and volume
• Why Vivani Medical, Inc.’s stock price changed recently
• Upgrades and downgrades for VANI from analysts
• VANI’s stock price momentum as measured by its relative strength

About Vivani Medical, Inc. (VANI)

Before we jump into Vivani Medical, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Want to learn more about Vivani Medical, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Vivani Medical, Inc..

Vivani Medical, Inc.’s Stock Price as of Market Close

As of July 24, 2026, 12:00 PM, CST, Vivani Medical, Inc.’s stock price was $1.320.

Vivani Medical, Inc. is down 5.03% from its previous closing price of $1.390.

During the last market session, Vivani Medical, Inc.’s stock traded between $1.310 and $1.370. Currently, there are approximately 81.27 million shares outstanding for Vivani Medical, Inc..

Vivani Medical, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Vivani Medical, Inc. Stock Price History

Vivani Medical, Inc.’s (VANI) price is currently up 6.46% so far this month.

During the month of July, Vivani Medical, Inc.’s stock price has reached a high of $1.660 and a low of $1.200.

Over the last year, Vivani Medical, Inc. has hit prices as high as $1.920 and as low as $0.923. Year to date, Vivani Medical, Inc.’s stock is up 7.33%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Vivani Medical, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 23, 2026, there were analysts who downgraded Vivani Medical, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Vivani Medical, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Vivani Medical, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Vivani Medical, Inc. (VANI) by visiting AAII Stock Evaluator.

Relative Price Strength of Vivani Medical, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 23, 2026, Vivani Medical, Inc. has a weighted four-quarter relative price strength of -4.66%, which translates to a Momentum Score of 40 and is considered to be Weak.

Want to learn more about how Vivani Medical, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Vivani Medical, Inc. Stock Price: Bottom Line

As of July 24, 2026, Vivani Medical, Inc.’s stock price is $1.320, which is down 5.03% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Vivani Medical, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.